Detalles de la búsqueda
1.
Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain.
BMC Public Health
; 21(1): 2182, 2021 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844567
2.
DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure.
Expert Rev Vaccines
; 22(1): 1196-1213, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37936265
3.
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series.
Vaccine
; 38(35): 5718-5725, 2020 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654902
4.
Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.
Vaccine
; 36(52): 8019-8027, 2018 12 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30471953
5.
Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
Vaccine
; 35(30): 3764-3772, 2017 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28583305
6.
DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers.
Expert Rev Vaccines
; 16(2): 85-92, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27996332
7.
Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.
Vaccine
; 35(3): 452-458, 2017 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27939054
8.
A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months.
Pediatr Infect Dis J
; 36(2): 209-215, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27846055
9.
A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.
Vaccine
; 34(33): 3810-6, 2016 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27288217
10.
Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children.
Pediatr Infect Dis J
; 24(3): 219-24, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15750457
11.
Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age.
Clin Vaccine Immunol
; 20(10): 1647-53, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23966556
12.
Safety and immunogenicity of fully liquid DTaP5-IPV-Hib pediatric combination vaccine (Pediacel®) compared to DTaP3-HBV-IPV/Hib (Infanrix® Hexa) when coadministered with heptavalent pneumococcal conjugate vaccine (PCV7) as a booster at 11-18 months of age: a phase III, modified double-blind, randomized, controlled, multicenter study.
Vaccine
; 30(35): 5270-7, 2012 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22691430
13.
Immunogenicity and safety of fully liquid DTaP5-IPV-Hib compared with DTaP3-IPV/Hib when both coadministered with a heptavalent pneumococcal conjugate vaccine (PCV7) at 2, 3, 4, and 12 to 18 months of age: a phase III, single-blind, randomised, controlled, multicentre study.
Vaccine
; 29(43): 7370-8, 2011 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-21807056
14.
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.
Vaccine
; 27(37): 5096-102, 2009 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-19573637
15.
Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age.
Vaccine
; 22(11-12): 1406-14, 2004 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-15063563
16.
Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster.
Vaccine
; 22(11-12): 1415-22, 2004 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-15063564
Resultados
1 -
16
de 16
1
Próxima >
>>